Abstract
Background
Network pharmacology approach has been observed a powerful tool to predict underlying complex pharmacological mechanism of herbs. Asparagus racemosus has been reported to show ameliorative effects in treating epilepsy and comorbid memory dysfunction but mechanism of this amelioration is elusive. Hence a network pharmacology approach was employed to investigate the plausible mechanism of A. recemosus.
Methodology
: Bioactive compounds of A. racemosus were extracted based on the TCMSP, PCIDB, and BATMAN-TCM database. The potential targets of bioactive compounds were collected using target fishing. Epilepsy and comorbid dementia genes were collected from DISGENET. A PPI network among these targets was constructed using the intersecting key targets between herb targets and disease targets. Besides, DAVID bioinformatics resource was utilized for the pathway enrichment analysis on GO and KEGG. Ultimately, phytochemical compound-target genes-Pathways network has been assembled utilizing Cytoscape to decipher the mechanism of the herb.
Results
The network analysis revealed that 5 targets (CASP3, TNF, VEGFA, PTGS2 and CNR1) might be the key therapeutic targets of asparagus on Epilepsy comorbid Alzheimer’s disease. Based on high connectivity, four hub compounds with the highest connectivity were noted and it includes Shatavarin V, Sarsasapogenin, Shatavarin IX, and Shatavarin VI. A total of 19 KEGG terms were enriched as the potential pathways of A. racemosus in Epilepsy comorbid Alzheimer’s disease.
Conclusion
This study envisaged the pharmacological and molecular mechanism of A. racemosus against epilepsy comorbid Alzheimer’s disease and put forward a strategy to uncover the mechanisms of Traditional Indian Medicine based on network pharmacology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Basavarajappa BS, Shivakumar M, Joshi V, Subbanna S (2017) Endocannabinoid system in neurodegenerative disorders. J Neurochem 142(5):624–648. https://doi.org/10.1111/jnc.14098Epub 2017 Jul 5. PMID: 28608560; PMCID: PMC5669051
Chandran U, Mehendale N, Patil S, Chaguturu R, Patwardhan B (2017) Network Pharmacology. Innovative approaches in Drug Discovery. 127–164. https://doi.org/10.1016/B978-0-12-801814-9.00005-2. Epub 2016 Oct 14. PMCID: PMC7148629
Chang R, Yee KL, Sumbria RK (2017) Tumor necrosis factor α inhibition for Alzheimer’s Disease. J Cent Nerv Syst Dis 9:1179573517709278. https://doi.org/10.1177/1179573517709278PMID: 28579870; PMCID: PMC5436834
Fakhfouri G, Ahmadiani A, Rahimian R, Grolla AA, Moradi F, Haeri A (2012) WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway. Neuropharmacology 63(4):653–666. https://doi.org/10.1016/j.neuropharm.2012.05.013Epub 2012 May 23. PMID: 22634229
Gadgil N (2021) EFFECT OF SHATAVARI (Asparagus racemosus) IN THE MANAGMENT OF EPILEPSY- A REVIEW 1 Dr Haseena K.A 2 Dr Neha Gadgil. Vol VI. 1798–1802
Garabadu D, Krishnamurthy S (2014) Asparagus racemosus attenuates anxiety-like behavior in experimental animal models. Cell Mol Neurobiol 34(4):511–521. https://doi.org/10.1007/s10571-014-0035-z
Haghani M, Shabani M, Javan M, Motamedi F, Janahmadi M (2012) CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones. Cell Physiol Biochem. ;29(3–4):391–406. doi: 10.1159/000338494. Epub 2012 Apr 3. PMID: 22508047
Henshall DC (2007) Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy. Biochem Soc Trans. ;35(Pt 2):421-3. https://doi.org/10.1042/BST0350421. PMID: 17371290
Henshall DC, Chen J, Simon RP (2000) Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures. J Neurochem. 74(3):1215-23. https://doi.org/10.1046/j.1471-4159.2000.741215.x. PMID: 10693954
Jones SV, Kounatidis I, Nuclear Factor-Kappa B, Disease A (2017) Unifying genetic and environmental risk factors from cell to humans. Front Immunol 8:1805. https://doi.org/10.3389/fimmu.2017.01805PMID: 29312321; PMCID: PMC5732234
Kashyap P, Muthusamy K, Niranjan M, Trikha S, Kumar S, Sarsasapogenin (2020) A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer’s disease. Steroids 153:108529. https://doi.org/10.1016/j.steroids.2019.108529Epub 2019 Oct 28. PMID: 31672628
Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH (2008) Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain 131(Pt 3):651–664. https://doi.org/10.1093/brain/awn008PMID: 18292081; PMCID: PMC2628581
Louneva N, Cohen JW, Han LY, Talbot K, Wilson RS, Bennett DA, Trojanowski JQ, Arnold SE (2008) Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer’s disease. Am J Pathol 173(5):1488–1495. https://doi.org/10.2353/ajpath.2008.080434Epub 2008 Sep 25. PMID: 18818379; PMCID: PMC2570138
Ohno-Shosaku T, Sawada S, Kano M (2000) Heterosynaptic expression of depolarization-induced suppression of inhibition (DSI) in rat hippocampal cultures. Neurosci Res. ;36(1):67–71. https://doi.org/10.1016/s0168-0102(99)00110-8. PMID: 10678533
Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A, Kano M (2002) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 22(10):3864–3872. https://doi.org/10.1523/JNEUROSCI.22-10-03864.2002PMID: 12019305; PMCID: PMC6757662
Pahwa P, Goel RK (2016) Ameliorative effect of Asparagus racemosus root extract against pentylenetetrazol-induced kindling and associated depression and memory deficit. Epilepsy Behav. ;57(Pt A):196–201. https://doi.org/10.1016/j.yebeh.2016.01.025. Epub 2016 Mar 11. PMID: 26970996
Rana A, Musto AE (2018) The role of inflammation in the development of epilepsy. J Neuroinflammation 15(1):144. https://doi.org/10.1186/s12974-018-1192-7PMID: 29764485; PMCID: PMC5952578
Ravizza T, Vezzani A (2018) Pharmacological targeting of brain inflammation in epilepsy: therapeutic perspectives from experimental and clinical studies. Epilepsia Open 3(Suppl Suppl 2):133–142. https://doi.org/10.1002/epi4.12242PMID: 30564772; PMCID: PMC6293065
REFRENCES
Rojas A, Jiang J, Ganesh T, Yang MS, Lelutiu N, Gueorguieva P, Dingledine R (2014) Cyclooxygenase-2 in epilepsy. Epilepsia 55(1):17–25. https://doi.org/10.1111/epi.12461Epub 2013 Nov 8. PMID: 24446952; PMCID: PMC3956447
Shastry RA, Madagundi SD, Habbu PV, Patil BS, Joshi SD, Kulkarni VH (2015) Phytochemical investigation and antiepileptic activity of Asparagus racemosus (Wild) root extracts in rodents. RGUHS J Pharm Sci 5(3):97–103
Singh R (2016) Asparagus racemosus: a review on its phytochemical and therapeutic potential. Nat Prod Res 30(17):1896–1908. https://doi.org/10.1080/14786419.2015.1092148Epub 2015 Oct 13. PMID: 26463825
Singh N, Garg M, Prajapati P, Singh PK, Chopra R, Kumari A, Mittal A (2023) Adaptogenic property of Asparagus racemosus: future trends and prospects. Heliyon 9(4):e14932. https://doi.org/10.1016/j.heliyon.2023.e14932PMID: 37095959; PMCID: PMC10121633
Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ (2001) Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol. ;428(1):51 – 7. https://doi.org/10.1016/s0014-2999(01)01243-2. PMID: 11779037
Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron. ;31(3):453 – 62. https://doi.org/10.1016/s0896-6273(01)00372-5. PMID: 11516401
Yermakova AV, O’Banion MK (2001) Nov-Dec;22(6):823 – 36 Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer’s disease. Neurobiol Aging. https://doi.org/10.1016/s0197-4580(01)00303-7. PMID: 11754989
Acknowledgements
Authors are grateful to the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala for providing the support to this research.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Baldeep Kaur: Data curation; Investigation; Methodology; Validation. Sandeep Kumar: Investigation; Methodology; Validation, Formal analysis. Arvinder Kaur: Writing manuscript; Formal analysis. Rajesh Kumar Goel: Conceptualization; Editing; Project administration; Resources; Supervision.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Authors’ statement
The data contained in this manuscript has not been published previously (except in the form of an abstract, a published lecture or academic thesis). It is not under consideration for publication elsewhere, its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright holder.
Competing interests
None.
Conflict of interest
Authors declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kaur, B., Kumar, S., Kaur, A. et al. A network pharmacology approach to explore pharmacological mechanisms of Asparagus racemosus for ameliorative effect in epilepsy and comorbid progressive memory dysfunction. In Silico Pharmacol. 11, 29 (2023). https://doi.org/10.1007/s40203-023-00169-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40203-023-00169-x